Preview

Journal of oncology: diagnostic radiology and radiotherapy

Advanced search

Promising Role of Postoperative Stereotactic Radiation Therapy for Patients with Prostate Cancer.

https://doi.org/10.37174/2587-7593-2025-8-2-9-22

Abstract

Radiation therapy is the standard therapeutic option in patients with prostate cancer (PCa) after radical prostatectomy (RPE), the indications for which are a high risk of postoperative progression (adjuvant radiation therapy) or registration of biochemical (clinical) recurrence of the disease (salvage radiation therapy). In recent years, studies have been conducted to assess the efficacy and safety of the use of hypofractionated radiation regimens in this category of patients, which significantly reduce the duration of treatment. Starting from 2016, the regimen of extreme hypofractionation or stereotactic radiation therapy (STRT) to the prostate bed (PB) began to be used in world practice, which makes it possible to deliver the prescribed dose in five-seven fractions. Currently, the N.N. Petrov National Medical Research Center of Oncology has matured long-term (more than five years) experience in performing STRT to the PB. The purpose of this work — to inform oncourologists, radiation oncologists and specialists in related areas with various aspects of a new perspective approach to postoperative radiation to the PB.

About the Authors

R. V. Novikov
N.N. Petrov National Medical Research Center of Oncology; S.M. Kirov Military Medical Academy, Ministry of Defense of the Russian Federation
Russian Federation


N. O. Kuznetsov
First Pavlov State Medical University of St. Petersburg
Russian Federation


S. N. Novikov
N.N. Petrov National Medical Research Center of Oncology
Russian Federation


References

1. .


Review

For citations:


Novikov R.V., Kuznetsov N.O., Novikov S.N. Promising Role of Postoperative Stereotactic Radiation Therapy for Patients with Prostate Cancer. Journal of oncology: diagnostic radiology and radiotherapy. 2025;8(2):9-22. (In Russ.) https://doi.org/10.37174/2587-7593-2025-8-2-9-22

Views: 108


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2587-7593 (Print)
ISSN 2713-167X (Online)